RT-qPCR analysis was performed on three sets of primary versus metastatic DSRCT tumors to evaluate the expression of SOX2 and NANOG, genes our previous analyses found are 1) associated with worse prognosis in sarcoma and 2) expressed at higher rates in DSRCT than at least one other type of fusion-positive sarcoma. This evidence concerns the gene SOX2 and sarcoma.